Live Chat
Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    J.D. Hoppenfeld, MD, Interventional Pain Management, Southeast Pain Care, Charlotte, North Carolina.
    Summary: "Some patients present with a primary complaint of pain while others complain of pain secondary to a more generalized disease process or procedure. As a healthcare professional, you are trained to diagnose the pathology and then treat it. A patient presents with pneumonia, your work-up supports the diagnosis; you treat it, then the patient gets better. However, another layer of patient care needs more focus in the medical community. If the patient with pneumonia complains of intercostal pain secondary to a violent cough, we have the ability to manage the symptoms of pain effectively, and should not hesitate to do so promptly. Our actions to alleviate pain will not hinder our ability to treat the underlying disease. Yet modern medicine often considers these goals mutually exclusive, with pain management a distance second. As medical professionals, when we have an incomplete understanding of how to treat a condition, we under treat it, erring on the side of do no harm. This book will give you the confidence to confront your patient's discomfort and succeed in conquering the pain"--Provided by publisher.
    Digital Access LWW Health Library 2014
  • Article
    MacDonald AL, Ohashi K, Basu PK.
    Can J Ophthalmol. 1978 Jul;13(3):182-5.
    Having shown that complement independent cellular cytotoxicity (CICC) plays a part in destroying the donor cell we wished to see if serum antibody cytotoxicity (SAC), complement dependent cellular cytotoxicity (CDCC) or K-cell mediated cellular cytotoxicity (KCC) might not also be involved in the rejection of corneal grafts. Rabbits were grafted with allo- and xenogreneic corneas. At various times, lymphoid cells and sera were collected from a recipient and a control animal. The donor's corneal cells and those of the control animal were cultivated in vitro, and then labelled with 51chromium. The recipient and control lymphoid cells and sera and/or complement were mixed with the labelled cells. A 51chromium release assay was done after incubation. The test was negative for SAC, CDCC, and KCC and we feel that they have no major part in the rejection of corneal grafts.
    Digital Access Access Options